Clinical Outcomes of Hepatoblastoma: An Experience of 37 Cases

Authors

  • Anan Sriniworn Department of Surgery, Queen Sirikit National Institute of Child Health, Bangkok, Thailand
  • Maitree Anuntkasol Department of Surgery, Queen Sirikit National Institute of Child Health, Bangkok, Thailand
  • Suranetr Laorwong
  • Wannisa Poocharoen Department of Surgery, Queen Sirikit National Institute of Child Health, Bangkok, Thailand
  • Rangsan Niramis Department of Surgery, Queen Sirikit National Institute of Child Health, Bangkok, Thailand

Keywords:

Hepatoblastoma, tumor resection, chemotherapy, survival rate

Abstract

Background: Hepatoblastoma is the most common malignant liver tumor occurring in young children. Results
of the treatment have continuously improved with increasing 5-year survival rates.
Objective: The aim of this study was to review clinical outcomes of hepatoblastoma in 11-year period.
Materials and Methods: A retrospective study was conducted including 37 patients with hepatoblastoma
treated at Queen Sirikit National Institute of Child Health between 2003 and 2013. Patients’ data were reviewed
including demographics, clinical presentations, investigations, staging, histopathological reports and treatment
outcome. Clinical information was expressed as percentage, range, mean, median, standard deviation and analyzed
with Chi-square test.
Results: Thirty-seven patients with hepatoblastoma, 20 males and 17 females, were treated during the study
period. Mean age at the operation was 23.0 ± 28.2 months (ranged from 2 months to 12 years). Abdominal mass and
abdominal distension were the principal complaints. Investigations by ultrasonography and computed tomography
scan were performed in 14 (37.8%) and 31cases (83.8%), respectively. Alpha-fetoprotein level at the time of diagnosis
ranged from 627 to 484,000 ng/ml and it returned to normal after the treatment in 15 of the 33 patients (45.5%). Of
the 37 patients, 9 (24.3%) were noted to have distant metastasis at the time of diagnosis. The tumor sites were located
in the right, left and bilateral hepatic lobes in 21 (56.8%), 11 (29.7%) and 5 cases (13.5%), respectively. Primary tumor
resection was performed in 9 patients (24.3%). The 28 remainders underwent liver biopsies. After chemotherapy,
the residual tumors were completely resected in 12 cases. The histological types were epithelial (59.5%),
mesenchymal (37.8%) and undifferentiated cell type (2.7%). Four patients (10.8%) died due to serious immediate
post operative complications; massive intraabdominal bleeding due to tumor rupture (2 cases), hepatic failure
(1case) and pneumonia (1case). Of the 33 survived patients, 12 (36.4%) were alive over 2 years and 9 (27.3%) were
doing well over 5 years after the first operation with the longest follow-up of 9-year period.
Conclusion: Hepatoblastoma was mostly found in children younger than three years. Only one-fourth of the
patients could undergo primary tumor resections, while the residual tumors could be resected after chemotherapy
in one-third of the remainders. The survival rates at 2 and 5 years were 36.4% and 27.3,%, respectively.

References

1. Tsay PD, Lai Jy, Yang CP, et al. Treatment outcomes for
hepatoblastoma : experience of 35 cases at a single institute.
J Formos Med Assoc 2011;110:322-5.

2. Ross JA. Hepatoblastoma and birth weight : too little, too big
or just right? J Pediatr 1997;130: 516-7.

3. Douglass EC, Reynolds M, Finegold M, et al. Cisplatin,
vincristine, and fluorouracil therapy for hepatoblastoma : a
Pediatric Oncology Group study. J Clin Oncol 1993; 11:96-9.

4. Ehrlich PF, Greenberg ML, Filler RM. Improved long-term
survival with preoperative chemotherapy for hepatoblastoma.
J Pediatr Surg 1997;32:999-1003.

5. von Schweinitz D, Byrd DJ, Hecker H, et al. Efficiency and
toxicity of ifosfamide, cisplatin and doxorubicin in the
treatment of childhood hepatoblastoma. Eur J Cancer
1997;33:1243-9.

6. Chiu SN, Ni YH, Lu My, et al. A trend of improved survival of
childhood hepatoblastoma treated with cisplatin and
doxorubicin in Taiwanese children. Pediatr Surg Int 2003;19:
593-7.

7. Suita S, Tajiri T, Takamatsu H, et al. Improved survival outcome
for hepatoblastoma based on an optimal chemotherapeutic regimen-a report from the study group for pediatric
solid malignant tumors in the Kyushu area. J Pediatr Surg
2004;39:195-8.

8. Bajpai M, Pal K, Agarwala S, et al. Midterm results with
hepatectomy after preoperative chemotherapy in
hepatoblastoma. Pediatr Surg Int 2005;21:364-8.

9. Anuntkosol M, Watanatittan S, Niramis R, et al. Primary
malignant hepatic tumors in children: fourteen - year
experience with 50 cases. Thai J Surg 2002;23:53-60.

10. Reynolds M, Pediatric liver tumor. Semin Surg Oncol 1999;
16:159-72.

11. Pierro A, Langevin AM, Filler RM, et al. Preoperative
chemotherapy in “unresectble” hepatoblastoma. J Pediatr
Surg 1989;24-8.

12. Stringer MD, Hennayake S, Howard ER, et al. Improved
outcome for children with hepatoblastoma. Br J Surg 1995;
82:386-91.

13. Chittmittrapap S, Imvised T, Vejchapipat P. Resection for
primary liver tumor in children : an experience of 52 cases at
one institute. J Med Assoc Thai 2008;91:1206-10.

14. Towu E, Kiely E, Pierro A, et al. Outcome and complications
after resection of hepatoblastoma, J Pediatr Surg 2004;39:
199-202.

15. von Schweinitz D, Hecker H, Harms D, et al. Complete
resection before development of drug resistance is essential
for survival from advanced hepatoblastoma - a report for
the German Cooperative Pediatric Liver Tumor Study HB-89.
J Pediatr Surg 1995;30:845-52.

16. King DR, Ortega J, Campbell J, et al. The surgical
management of children with incomplete hepatic cancer
is facilitated by intensive chemotherapy. J Pediatr Surg
1991;26:1074-81.

17. Filler RM, Enrlich PE, Greenberg ML. Preoperative
chemotherapy in hepatoblastoma. Surgery 1991;110;591-7.

18. Haas JE, Muezynski KA, Krailo M, et al. Histopathology and
prognosis in childhood hepatoblastoma and hepatocarcinoma.
Cancer 1989;64:1082-95.

19. Gonzales-Crussi F. Undifferentiated small cell (anaplastic)
hepatoblastoma. Pediatr Pathol 1991;11:155-62

Downloads

Published

2015-12-30

How to Cite

1.
Sriniworn A, Anuntkasol M, Laorwong S, Poocharoen W, Niramis R. Clinical Outcomes of Hepatoblastoma: An Experience of 37 Cases. Thai J Surg [Internet]. 2015 Dec. 30 [cited 2024 Mar. 29];36(4). Available from: https://he02.tci-thaijo.org/index.php/ThaiJSurg/article/view/226057

Issue

Section

Original Articles